Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Austin, Texas 78744


Purpose:

This is a Phase 1 study, involving both 1-day and 8-day dosing periods, designed to test the safety of investigational study drug ARRY-371797 in healthy subjects. Approximately 48 healthy subjects from the US will be enrolled in this study.


Criteria:

Key Inclusion Criteria: - Healthy male or female between the ages of 18 and 60 years. - Females must be of nonchildbearing potential. - Body weight > 50 kg (110 lbs) and < 113 kg (250 lbs). - Additional criteria exist. Key Exclusion Criteria: - A positive test for drugs or alcohol. - Use of prescription or nonprescription drugs, herbal or dietary supplements, vitamins, or grapefruit juice within 14 days prior to first dose of study drug. - Additional criteria exist.


NCT ID:

NCT00790049


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Austin, Texas 78744
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.